
# Title 42 - Public Health
## Chapter IV - Centers for Medicare & Medicaid Services, Department of Health and Human Services
### Subchapter B - Medicare Program
#### PART 413 - PRINCIPLES OF REASONABLE COST REIMBURSEMENT; PAYMENT FOR END-STAGE RENAL DISEASE SERVICES; PROSPECTIVELY DETERMINED PAYMENT RATES FOR SKILLED NURSING FACILITIES; PAYMENT FOR ACUTE KIDNEY INJURY DIALYSIS
##### Subpart H - Payment for End-Stage Renal Disease (ESRD) Services
###### ยง 413.234 Drug designation process.
####### Type 9,Type 9,Type 9,Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees.

(A) ANDA is for a new indication or claim for a drug product that is currently being reviewed under a different NDA (the "parent NDA"), and the applicant does not intend to market this drug product under theNDA after approval. Generally, aNDA is submitted as a separate NDA so as to be in compliance with the guidance for industry on
